华海药业 (600521)
Zhejiang Huahai Pharmaceutical Co., Ltd.
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 149725.14
- Circulating A-Shares(W): 149725.14
- Earnings Per Share(RMB): 0.2600
- Net Assets Per Share(RMB): 6.1912
- Operating Revenue(W RMB): 640888.19
- Total Profit(W RMB): 54915.67
- **Net Profit Attributable to Parent(W RMB) **: 38035.63
- Net Profit Growth Rate(%): -63.12
- Weighted Return on Equity(%): 4.0100
- Operating Cash Flow Per Share(RMB): 0.4360
- Undistributed Profit Per Share(RMB): 3.7156
- Capital Reserve Per Share(RMB): 1.0416
2. Main Business
The main business covers:
- Research, development, production, and sales of multi-dosage form preparations
- Research, development, production, and sales of biologics
- Research, development, production, and sales of innovative drugs and specialty APIs
3. Company Basic Information
- Company Name: Zhejiang Huahai Pharmaceutical Co., Ltd.
- Listing Date: 2003-03-04
- Industry: Pharmaceutical Manufacturing
- Address: Xunqiao, Linhai City, Zhejiang Province
- Website: https://www.huahaipharm.com
- Company Profile: On December 29, 1988, Chen Baohua, Zhou Minghua, Weng Jinying, and Wang Qiang signed a capital contribution agreement, each contributing 12,500 yuan to jointly establish Linhai Xunqiao Synthetic Chemical Factory. The business license (Lin Gong Shang 6137) was obtained on January 7, 1989. The enterprise was a labor cooperative system enterprise, with shareholders contributing capital in cash, and the registered capital was 50,000 yuan. The business scope was the processing and sales of Cholagogue crude product; the enterprise was jointly operated by Chen Baohua, Zhou Minghua, and Weng Jinying. Approved by the National Medical Products Administration, Zhejiang Huahai Pharmaceutical Chemical Co., Ltd. established Zhejiang Huahai Pharmaceutical Co., Ltd. Approved by the Zhejiang Provincial Administration for Industry and Commerce, the company changed its name to Zhejiang Huahai Pharmaceutical Co., Ltd. on February 3 of the same year, with a registered capital of 17 million yuan, business license number 3310821000595 (1/1), and the business scope added pharmaceuticals, preparations, APIs, etc.; from then on, the company transformed into a pharmaceutical enterprise.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | China Europe Healthcare Hybrid Securities Investment Fund Class A | Fund | 2878.50 | 1.92 |
| 2 | Hong Kong Securities Clearing Company Ltd. | Northbound Capital | 2124.62 | 1.42 |
| 3 | Guotai Asset Management Co., Ltd. - Social Security Fund 2103 Portfolio | Social Security Fund | 1668.64 | 1.11 |
| 4 | Fullgoal Enhanced Bond Securities Investment Fund Class A | Fund | 1343.23 | 0.90 |
| 5 | Guotai Jiatai Stock Special Pension Product - China Merchants Bank Co., Ltd. | Asset Management Plan | 1332.51 | 0.89 |
| 6 | CSI 500 Exchange Traded Open End Index Securities Investment Fund | Fund | 1316.75 | 0.88 |
| 7 | Taizhou Financial Investment Group Co., Ltd. | General Legal Person | 1246.29 | 0.83 |
| 8 | Invesco Great Wall Trend Investment Mixed Securities Investment Fund (LOF) | Fund | 1238.13 | 0.83 |
| 9 | E Fund Pharmaceutical Health Theme Equity Initiated Securities Investment Fund Class A | Fund | 452.10 | 0.30 |
| 10 | China Merchants Pharmaceutical Health Industry Equity Securities Investment Fund | Fund | 305.77 | 0.20 |
5. Concept Sectors
- Convertible Bonds
- Immunotherapy
- Generic Drugs
- Innovative Drugs
- Synthetic Biology
- Margin Trading & Securities Lending
- Social Security Fund Heavy Positions
- Shareholding in New Listings
- MSCI Mid Cap
- Non-Cyclical Stocks
- Private Placement Heavy Positions
- SSE 380
- Private Enterprise 100
- Innovation 100
Remarks
- Data update date: 2025-10-30
- Data source: Public Market Information